Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138+ cells

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Podar K, Richardson PG, Hideshima T, Chauhan D, Anderson KC . The malignant clone and the bone-marrow environment. Best Pract Res Clin Haematol 2007; 20: 597–612.

    Article  CAS  PubMed  Google Scholar 

  2. Vacca A, Ribatti D, Presta M, Minischetti M, Iurlaro M, Ria R et al. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 1999; 93: 3064–3073.

    CAS  PubMed  Google Scholar 

  3. Brahimi-Horn MC, Chiche J, Pouysségur J . Hypoxia and cancer. J Mol Med 2007; 85: 1301–1307.

    Article  PubMed  Google Scholar 

  4. Weidemann A, Johnson RS . Biology of HIF-1α. Cell Death Differ 2008; 15: 621–627.

    Article  CAS  PubMed  Google Scholar 

  5. Harrison JS, Rameshwar P, Chang V, Bandari P . Oxygen saturation in the bone marrow of healthy volunteers. Blood 2002; 99: 394.

    Article  CAS  PubMed  Google Scholar 

  6. Kumar S, Witzig TE, Timm M, Haug J, Wellik L, Kimlinger TK et al. Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression. Blood 2004; 104: 1159–1165.

    Article  CAS  PubMed  Google Scholar 

  7. Hose D, Moreaux J, Meissner T, Seckinger A, Goldschmidt H, Benner A et al. Induction of angiogenesis by normal and malignant plasma cells. Blood 2009; 114: 123–148.

    Article  Google Scholar 

  8. Asosingh K, De Raeve H, de Ridder M, Storme GA, Willems A, Van Riet I et al. Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression. Haematologica 2005; 90: 810–817.

    CAS  PubMed  Google Scholar 

  9. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004; 10: 858–864.

    Article  CAS  PubMed  Google Scholar 

  10. Stewart M, Talks K, Leek R, Turley H, Pezzella F, Harris A et al. Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin's lymphoma. Histopathology 2002; 40: 253–260.

    Article  CAS  PubMed  Google Scholar 

  11. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D et al. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 1999; 59: 5830–5835.

    CAS  PubMed  Google Scholar 

  12. Shin DH, Chun YS, Lee DS, Huang LE, Park JW . Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1. Blood 2008; 111: 3131–3136.

    Article  CAS  PubMed  Google Scholar 

  13. Lu L, Payvandi F, Wu L, Zhang LH, Hariri RJ, Man HW et al. The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions. Microvasc Res 2009; 77: 78–86.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank the ‘Associazione Italiana Contro le Leucemie’ (AIL) Parma section and the Associazione Italiana Ricerca sul Cancro (AIRC) for the financial support (IG2009). This study was supported by grants from the ‘International Myeloma Foundation’; the ‘Italian Minister of Health-Progetti Regione Emilia Romagna’.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to N Giuliani.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Colla, S., Storti, P., Donofrio, G. et al. Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138+ cells. Leukemia 24, 1967–1970 (2010). https://doi.org/10.1038/leu.2010.193

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2010.193

This article is cited by

Search

Quick links